These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6434581)

  • 21. Nonspecific growth hormone responses to thyrotropin-releasing hormone in insulin-dependent diabetes: sex- and age-related pituitary responsiveness.
    Ceda GP; Speroni G; Dall'Aglio E; Valenti G; Butturini U
    J Clin Endocrinol Metab; 1982 Jul; 55(1):170-4. PubMed ID: 6804482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Growth hormone secretion in response to the administration of thyrotropin releasing hormone (TRH) in children with insulin-dependent diabetes mellitus].
    Saggese G; Cesaretti G; Bracaloni C; Calisti L; Carlotti C; Cioni C
    Minerva Pediatr; 1992 May; 44(5):195-204. PubMed ID: 1620073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of growth hormone-releasing hormone and clonidine on growth hormone release in type 1 diabetic patients.
    Giampietro O; Ferdeghini M; Miccoli R; Locatelli V; Cerri M; Yanaihara N; Navalesi R; Müller EE
    Horm Metab Res; 1987 Dec; 19(12):636-41. PubMed ID: 3126122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cholinergic blockade on nocturnal thyrotropin and growth hormone (GH) secretion in type I diabetes mellitus: further evidence supporting somatostatin's involvement in GH suppression.
    Goñi MJ; Monreal M; Goñi F; Sopena M; Gil MJ; Moncada E; Salvador J
    Metabolism; 1997 Nov; 46(11):1305-11. PubMed ID: 9361690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects.
    Arends J; Wagner ML; Willms BL
    J Clin Endocrinol Metab; 1988 Feb; 66(2):389-94. PubMed ID: 3339112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone response to thyrotropin-releasing hormone in the urethane-anesthetized rat: effect of thyroid status.
    Szabo M; Ruestow PC; Kramer DE
    Endocrinology; 1985 Jul; 117(1):330-7. PubMed ID: 3924582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mechanism of growth hormone and thyrotropin responses to somatostatin antiserum in anesthetized rats.
    Chihara K; Arimura A; Chihara M; Schally AV
    Endocrinology; 1978 Nov; 103(5):1916-23. PubMed ID: 107024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discordant effects of insulin-hypoglycemia on growth hormone (GH)-releasing hormone-stimulated GH and thyrotropin (TSH)-releasing hormone-stimulated TSH secretion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1988 Apr; 66(4):872-5. PubMed ID: 3126217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous growth hormone (GH) pulsatility is the major determinant of GH release after thyrotrophin-releasing hormone in adolescent diabetics.
    Edge JA; Human DH; Matthews DR; Dunger DB
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):397-404. PubMed ID: 2513149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histamine-induced paradoxical growth hormone response to thyrotropin-releasing hormone in normal men.
    Knigge U; Thuesen B; Wollesen F; Dejgaard A; Christiansen PM
    J Clin Endocrinol Metab; 1984 Apr; 58(4):692-7. PubMed ID: 6421867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical response of growth hormone to peptide histidine methionine in acromegaly: comparison with the effects of thyrotropin-releasing hormone and vasoactive intestinal peptide.
    Watanobe H; Sasaki S; Sone K; Takebe K
    J Clin Endocrinol Metab; 1991 May; 72(5):982-5. PubMed ID: 1902488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower 24-hour growth hormone levels in type I diabetics responding to thyrotropin-releasing hormone (TRH).
    Krassowski J; Szulc P; Kurta J; Jeske W; Zgliczyński S
    Endokrynol Pol; 1992; 43(3):336-42. PubMed ID: 1345574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D
    Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of thyrotropin releasing hormone injection on blood growth hormone (GH), TSH and growth hormone releasing hormone (GHRH) concentrations in cancer patients.
    Kamijo K; Kawasaki K; Sato M; Yachi A; Bannai S; Takanashi N
    Endocrinol Jpn; 1988 Dec; 35(6):827-31. PubMed ID: 2907988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pasma growth hormone responses to thyrotropin-releasing hormone in the urethane-anesthetized rat.
    Kato Y; Chihara K; Maeda K; Ogo S; Okanishi Y
    Endocrinology; 1975 May; 96(5):1114-8. PubMed ID: 804399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth rate and secretion of pituitary hormones in relation to age and chronic treatment with thyrotropin-releasing hormone in prepubertal dairy heifers.
    Davis SL; Sasser RG; Thacker DL; Ross RH
    Endocrinology; 1977 May; 100(5):1394-402. PubMed ID: 191244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
    Spoudeas HA; Matthews DR; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 1992 Aug; 75(2):453-8. PubMed ID: 1353504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.